The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Satyavathi Bandaram & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Promoters and persons acting in concert (PACs) of Bandaram Pharma Packtech acquired 22,54,484 equity shares (12.54% of expanded capital) through a preferential allotment on November 6, 2025. The biggest buyers were Deepak Reddy B (16,07,996 shares, 8.94%) and Prajitha Bandaram (4,86,488 shares, 2.71%), with smaller tranches to Satyavathi Bandaram and B Premsai Reddy (80,000 shares each). The company's total equity capital expanded from Rs. 12 crore (1.2 crore shares) to Rs. 17.97 crore (1.797 crore shares), meaning roughly 59.7 lakh new shares were issued, of which about 22.5 lakh went to the promoter group and the rest to outside investors. Consequently, promoter group absolute holdings rose from 90 lakh to 1,12,54,484 shares, but their percentage stake actually fell from 75% to 62.62% due to dilution. No encumbrances (pledge/lien) were created or invoked as part of this transaction.
Promoters demonstrated commitment by participating in the preferential issue, but their effective control was diluted from 75% to 62.62%. The sizeable equity expansion signals a fresh capital raise that could fund growth, though shareholders should track the use of proceeds and the identity of the other allottees who absorbed the remaining ~37 lakh new shares.